2006
DOI: 10.1016/j.jbiotec.2005.12.028
|View full text |Cite
|
Sign up to set email alerts
|

Production of hantavirus Puumala nucleocapsid protein in Saccharomyces cerevisiae for vaccine and diagnostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
0
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(17 citation statements)
references
References 44 publications
0
16
0
1
Order By: Relevance
“…Yet with all of these purported advantages, heterologous protein expression in yeast, in many instances, is far from optimal, with yields as low as micrograms per liter (11a, 35). However, yeast protein production capacity in general terms is much higher, given the ability to secrete certain proteins at levels approaching a gram per liter (1,24).…”
mentioning
confidence: 99%
“…Yet with all of these purported advantages, heterologous protein expression in yeast, in many instances, is far from optimal, with yields as low as micrograms per liter (11a, 35). However, yeast protein production capacity in general terms is much higher, given the ability to secrete certain proteins at levels approaching a gram per liter (1,24).…”
mentioning
confidence: 99%
“…Continuous culture maintains cells in stationary state (chemostat) with a constant supply of culture medium and cells; it is usually designed for producing a high volume of low value products associated to growth, typically primary metabolites and biomass (Bondarev et al 2003 ;Antoniukas et al 2006 ;Desai et al 2006 ).…”
Section: Culture Medium Selectionmentioning
confidence: 99%
“…A fused galactose inducible GAL10-PYK promoter has recently been used for the production of high levels of hantavirus Puumala nucleocapsid (N) protein (316 mg/l) (Antoniukas et al 2006), and the HeV and NiV nucleocapsid proteins from Hendra and Nipah viruses, has been productively expressed (18-20 mg/l) in S. cerevisiae under the control of the GAL7 promoter (Juozapaitis et al 2007). A GAL1 promoter has also been used to drive the expression of a heterologous dextranase gene in S. cerevisiae, in order to develop a novel toxicity bioassay (Li et al 2006).…”
Section: Controlled Expression Using Endogenous Promotersmentioning
confidence: 99%